Legal & General Group PLC Astrazeneca PLC Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Legal & General Group PLC holds 435,273 shares of AZN stock, worth $38.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

435,273

Previous 624,858 30.34%

Holding current value

$38.9 Million

Previous $43.7 Million 23.52%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$68.72 - $82.11 $13 Million - $15.6 Million	-189,585 Reduced 30.34%	435,273 $33.4 Million
Q2 2025 Aug 12, 2025	SELL	$64.87 - $75.0 $3.7 Million - $4.28 Million	-57,065 Reduced 8.37%	624,858 $43.7 Million
Q1 2025 May 15, 2025	SELL	$65.37 - $77.96 $8.28 Million - $9.87 Million	-126,624 Reduced 15.66%	681,923 $50.1 Million
Q4 2024 Feb 13, 2025	SELL	$63.2 - $79.58 $6.36 Million - $8.01 Million	-100,629 Reduced 11.07%	808,547 $53 Million
Q3 2024 Feb 28, 2025	BUY	$76.67 - $87.62 $7.65 Million - $8.74 Million	99,789 Added 12.34%	908,336 $70.8 Million

Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $1.21 Million - $1.38 Million	-15,796 Reduced 1.71%	909,176 $70.8 Million
Q2 2024 May 29, 2025	SELL	$66.81 - $80.83 $1.16 Million - $1.4 Million	-17,343 Reduced 1.84%	924,132 $72.1 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $1.1 Million - $1.33 Million	-16,503 Reduced 1.75%	924,972 $72.1 Million
Q1 2024 May 29, 2025	BUY	$61.03 - $69.57 $15.8 Million - $18.1 Million	259,552 Added 38.06%	941,475 $63.8 Million
Q1 2024 Jul 01, 2024	BUY	$61.03 - $69.57 $496,051 - $565,464	8,128 Added 0.87%	941,475 $63.8 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $943,523 - $1.08 Million	-15,460 Reduced 1.63%	933,347 $63.2 Million
Q4 2023 May 29, 2025	BUY	$61.89 - $69.28 $16.5 Million - $18.5 Million	266,884 Added 39.14%	948,807 $63.9 Million
Q4 2023 Feb 15, 2024	SELL	$61.89 - $69.28 $2.74 Million - $3.07 Million	-44,323 Reduced 4.46%	948,807 $63.9 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $277,104 - $306,374	-4,273 Reduced 0.43%	993,130 $67.3 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $17.4 Million - $18.9 Million	-249,401 Reduced 20.0%	997,403 $71.4 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $5.98 Million - $6.78 Million	-94,732 Reduced 7.06%	1,246,804 $86.5 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $6.66 Million - $8.65 Million	-122,869 Reduced 8.39%	1,341,536 $91 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $39.3 Million - $101 Million	-741,455 Reduced 33.61%	1,464,405 $80.3 Million
Q2 2022 Aug 22, 2022	SELL	$59.26 - $71.14 $36.8 Million - $44.1 Million	-620,559 Reduced 21.96%	2,205,860 $146 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $68.1 Million - $82 Million	-1,222,429 Reduced 30.19%	2,826,419 $187 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $77.1 Million - $91.1 Million	-1,427,165 Reduced 26.06%	4,048,848 $236 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $304 Million - $333 Million	5,476,013 New	5,476,013 $329 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $29.6 Million - $35.4 Million	-610,660 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $32.4 Million - $37.3 Million	610,660 New	610,660 $33.5 Million
Q4 2019 Feb 13, 2020	SELL	$42.46 - $50.46 $10.2 Million - $12.1 Million	-240,448 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $9.65 Million - $10.9 Million	240,448 New	240,448 $10.7 Million

Others Institutions Holding AZN

# of Institutions

1,541

Shares Held

503M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Astrazeneca PLC Transaction History